IMMUNE CHECKPOINT INHIBITORS (ICIS)
Clinical trials for IMMUNE CHECKPOINT INHIBITORS (ICIS) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS (ICIS) trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS (ICIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer trial targets hidden DNA to delay progression
Disease control Recruiting nowThis study tests whether adding a new drug (ivonescimab) to standard chemotherapy can help people with advanced non-small cell lung cancer who have done well on initial immunotherapy but still have cancer DNA in their blood. About 70 participants will receive either the new combi…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS (ICIS)
Phase: PHASE2 • Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Lung cancer clot risk under microscope in 2,400-Patient study
Knowledge-focused Recruiting nowThis study watches 2,400 lung cancer patients who are getting immunotherapy (immune checkpoint inhibitors) to see how often they develop dangerous blood clots. Researchers will compare patients who get clots with those who don't, looking for clues in their health records and lab …
Matched conditions: IMMUNE CHECKPOINT INHIBITORS (ICIS)
Sponsor: Beijing Chao Yang Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:52 UTC